Kinarus

Kinarus Therapeutic Holding AG Interim data from Phase 2 KINETIC clinical trial of KIN001 to treat hospitalized COVID-19 patients expected in Q3 2022 First patient dosed with in Phase 2 KINFAST clinical trial with ambulatory COVID-19 mild-patients Signed a CHF 20 million financing with Yorkville Advisors Fully financed until Q1 […]